Lonza to Acquire a U.S. Clinical Manufacturing Site from Shire

News   Oct 03, 2017

 
Lonza to Acquire a U.S. Clinical Manufacturing Site from Shire
 
 
 

RELATED ARTICLES

Bacteria Produce More Substances Than Genetics Predicted

News

Tandem mass spectrometry has revealed that Streptomyces chartreusis, an antibiotic-producing bacterium, releases more metabolites into the surrounding medium than scientists assumed based on the analysis of the genome. They might include molecules that are of interest as potential pharmaceutical agents.

READ MORE

Gut Bacteria Latest Ally in Fight Against Sepsis

News

Sepsis occurs when the body's response to the spread of bacteria or toxins to the bloodstream damages tissues and organs. The fight against sepsis could get a helping hand from a surprising source: gut bacteria. Researchers found that giving mice particular microbes increased blood levels of immunoglobulin A (IgA) antibodies, which protected against the kind of widespread bacterial invasion that leads to sepsis.

READ MORE

Symmetry-breaking Method Opens Way for Bioactive Compounds

News

EPFL chemists have developed a new catalytic method for symmetry breaking. Published in Angewandte Chemie, the method can help synthesize important building blocks for bioactive compounds such as anticancer drugs.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Cell Science Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE